All articles published by MDPI are made immediately available worldwide under an open access license. No special
permission is required to reuse all or part of the article published by MDPI, including figures and tables. For
articles published under an open access Creative Common CC BY license, any part of the article may be reused without
permission provided that the original article is clearly cited. For more information, please refer to
https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature
Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for
future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive
positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
Editors select a small number of articles recently published in the journal that they believe will be particularly
interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the
most exciting work published in the various research areas of the journal.
“Epitope Editing Enables Targeted Immunotherapy of Acute Myeloid Leukemia” by Gabriele Casirati, Boston Children's Hospital, MA, USA
“The Local Microenvironment Drives Activation of Neutrophils in Human Brain Tumors” by Roeltje Maas, Université de Lausanne, Switzerland
Each winner will receive CHF 800, a certificate and a chance to publish a paper free of charge after peer review in Cancers in 2024.
On behalf of the evaluation committee, I congratulate the winners on their accomplishments. We would like to take this opportunity to thank all the applicants for submitting their exceptional theses, and thank the Award Committee for voting and helping with this award.
Prof. Dr. Samuel C. Mok Editor-in-Chief, Cancers
Cancers 2023 Best PhD Thesis Award
Past Winners
Year:
Winner
Benjamin Genenger
University of Wollongong, Australia
Diana Pádua
Institute of Molecular Pathology and Immunology of the University of Porto, Portugal
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center
Dr. Jason Roszik
University of Texas MD Anderson Cancer Center
Prof. Dr. Andreas Leithner
Department of Orthopaedics and Trauma, Medical University of Graz
Dr. Kevin A. Camphausen
NCI
Winner
Gabriele Casirati
Boston Children's Hospital, MA, USA
Roeltje Maas
Université de Lausanne, Switzerland
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center
Dr. Farrukh Aqil
University of Louisville
Prof. Alexandre Escargueil
Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine
Dr. Shinji Miwa
Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University
Dr. Kevin A. Camphausen
NCI
Winner
João Pedro da Silva Machado Lobo
Instituto Portugues de Oncologia de Francisco Gentil Porto, Portugal
Adrià Cañellas Socias
IRB Barcelona, Spain
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center
Prof. Craig N. Robson
Newcastle University
Prof. Dr. Dik C. van Gent
Department of Molecular Genetics, Erasmus MC, Univesity Medical Center Rotterdam
Prof. Alexandre Escargueil
Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine
Prof. Brian Gabrielli
Mater Research Institute - The University of Queensland
Dr. Aamir Ahmad
Hamad Medical Corporation
Dr. Ognjen Arandjelovic
University of St Andrews
Prof. Andrea Morrione
Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Department of Biology, Temple University
Prof. Raffaele Capasso
University of Naples Federico II
Prof. Ajay Singh
Winner
Michael Rückert
Universitätsklinikum Erlangen, Germany
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center
Dr. Sharon McKenna
University College Cork
Dr. Marc Poirot
Cancer Research Center of Toulouse, UMR 1037 Inserm-UMR 5071 CNRS, University of Toulouse III
Dr. Sam Mbulaiteye
National Cancer Institute
Dr. Leonhard Müllauer
Medizinische Universität Wien
Prof. Hajime Isomoto
Prof. Dr. Spencer B Gibson
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.
